Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: A randomized controlled trial

Journal of Perinatology

Volumn 29, Issue 6, 2009, Pages 438-443

  Aly, H ^a   Abd Rabboh, L ^b   El Dib, M ^a   Nawwar, F ^b   Hassan, H ^b   Aaref, M ^b   Abdelrahman, S ^b   Elsayed, A ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CYTOKINE; IBUPROFEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLACEBO;

ARTICLE; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVELOPMENTAL DISORDER; DEVELOPMENTAL SCREENING; DIGESTIVE SYSTEM PERFORATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEWBORN; NEWBORN HYPOXIA; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTE COUNT; TREATMENT DURATION;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ASCORBIC ACID; ASPHYXIA NEONATORUM; DEVELOPMENTAL DISABILITIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; IBUPROFEN; INFANT, NEWBORN; MALE;

EID: 67349096792     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.1     Document Type: Article

References (22)

1. Azra Haider B, Bhutta ZA. Birth asphyxia in developing countries: current status and public health implications. Curr Probl Pediatr Adolesc Health Care 2006; 36: 178-188.
2. Marro PJ. The etiology and pharmacologic approach to hypoxic-ischemic encephalopathy in the newborn. Neoreviews 2002; 3: E99-e107.
3. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001; 21: 2-14.
4. Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 1999; 13: 1007-1024.
5. Halliwell B, Gutteridge JM. Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts. Arch Biochem Biophys 1986; 246: 501-514.
6. Neuzil J, Thomas SR, Stocker R. Requirement for, promotion, or inhibition by alphatocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med 1997; 22 57-71.
7. MacGregor DG, Higgins MJ, Jones PA, Maxwell WL, Watson MW, Graham DI et al. Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus. Brain Res 1996; 727: 133-144.
8. Miura S, Ishida A, Nakajima W, Ohmura A, Kawamura M, Takada G. Intraventricular ascorbic acid administration decreases hypoxic-ischemic brain injury in newborn rats. Brain Res 2006; 1095: 159-166.
9. Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev 2006; 28: 178-182.
10. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia - ischemia in neonatal rats. Pediatr Res 1996; 40: 603-609.
11. Rainsford KD. Discovery, mechanisms of action and safety of ibuprofen. Int J Clin Pract Suppl 2003; 135: 3-8.
12. Antezana DF, Clatterbuck RE, Alkayed NJ, Murphy SJ, Anderson LG, Frazier J et al. High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats. J Neurosurg 2003; 98: 860-866.
13. Grice SC, Chappell ET, Prough DS, Whitley JM, Su M, Watkins WD. Ibuprofen improves cerebral blood flow after global cerebral ischemia in dogs. Stroke 1987; 18: 787-791.
14. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976; 33: 696-705.
15. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick B. The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics 1992; 89: 91-97.
16. Helle M, Boeije L, de Groot E, de Vos A, Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: Synovial fluids and sera. J Immunol Methods 1991; 138: 47-56.
17. Bass WT, Malati N, Castle MC, White LE. Evidence for the safety of ascorbic acid administration to the premature infant. Am J Perinatol 1998; 15: 133-140.
18. Kokki H, Kumpulainen E, Lehtonen M, Laisalmi M, Heikkinen M, Savolainen J et al. Cerebrospinal fluid distribution of ibuprofen after intravenous administration in children. Pediatrics 2007; 120 e1002-e1008.
19. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral Ibuprofen and ductus arteriosus in premature infants: A randomized pilot study. Am J Perinatol 2007; 24: 267-270.
20. Schultz SJ, Aly H, Hasanen BM, Khashaba MT, Lear SC, Bendon RW et al. Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxicischemic central nervous system of human newborn infants. Neurosci Lett 2005; 378: 1-6.
21. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet 2005; 365: 663-670.
22. Hallioglu O, Topaloglu AK, Zenciroglu A, Duzovali O, Yilgor E, Saribas S. Denver developmental screening test II for early identification of the infants who will develop major neurological deficit as a sequalea of hypoxic-ischemic encephalopathy. Pediatr Int 2001; 43: 400-404.